In a nutshell This study is comparing the effectiveness of two insulin delivery systems for patients with type 1 diabetes (T1D). The authors concluded that the Diabeloop system was more effective and better reduced high blood glucose levels in these patients. Some background Controlling blood glucose levels is an essential part of diabetes management....
Read More
In a nutshell This study compared the effectiveness and safety of a closed-loop and sensor-augmented insulin pumps for patients with Type 1 diabetes (T1D). The authors found that the closed-loop device was more effective but had more side effects for these patients. Some background The main goal of treatment for T1D is to balance blood glucose...
Read More
In a nutshell This study evaluated the safety and effectiveness of ipragliflozin (Suglat) in patients with type 2 diabetes (T2D). This study concluded that ipragliflozin helped reduce insulin dose by 30%, with minimal side effects. Some background Treatment for T2D aims to achieve good blood glucose control while avoiding hypoglycemia (dangerously low...
Read More
In a nutshell This study evaluated whether the ‘suspend-before-low’ feature of automatic insulin pumps prevented hypoglycemia (HG) in patients with Type 1 diabetes (T1D). The authors concluded that this feature successfully reduced the rate of HG and was not associated with increased side effects. Some background The goal of...
Read More
In a nutshell This study compared insulin degludec/liraglutide (IDegLira) to standard insulin in patients with uncontrolled Type 2 diabetes (T2D). The authors concluded that IDegLira improved patient compliance to treatment and reduced treatment-related stress compared to conventional insulin. Some background One of the main goals of treatment...
Read More
In a nutshell This study examined if nutritional supplements can reduce the rate of hypoglycemia in patients with Type 2 diabetes (T2D). This study concluded that these supplements helped reduce hypoglycemia and lowered mortality risk for these patients. Some background Treatment for T2D, such as insulin, can cause blood sugar levels to...
Read More
In a nutshell This study examined whether sotagliflozin (Zynquista) helped improve kidney function in patients with Type 1 diabetes (T1D). The authors concluded that sotagliflozin improved several factors of kidney function. Some background The goal of treatment for patients with T1D is to lower blood...
Read MoreIn a nutshell This study is comparing the effectiveness of two types of insulin when they are given using an automated insulin pump to patients with type 1 diabetes (T1D). The main outcome will be to examine patients’ blood glucose levels after 6 weeks. This study is recruiting in Austin, TX, US. The details T1D is a disease where...
Read More
In a nutshell This study examined if linagliptin (Tradjenta) was safer and more effective in older patients with Type 2 diabetes compared to a placebo. This study concluded that linagliptin helped improve glucose control for these patients without causing additional side effects. Some background About 90% of diabetes cases are of Type 2 diabetes...
Read More
In a nutshell This article investigated the safety and effectiveness of sitagliptin (Januvia) in the management of type 2 diabetes (T2D) in elderly patients on insulin. The authors concluded that the addition of sitagliptin is effective and safe in all patients receiving it as add-on therapy to insulin. Some background In type 2...
Read More
In a nutshell The aim of this study was to determine whether a combination of a new insulin dosing system, the d-Nav device and the support of a healthcare professional (HCP) is better than support by an HCP alone. The main finding of the study was that the d-Nav device and HCP together offer better blood sugar control than just the HCP support...
Read MoreIn a nutshell This trial is examining the effectiveness of a dual-hormone (insulin and glucagon) pump compared to insulin only pump and a predictive low glucose management (PLGM) system in patients with type 1 diabetes (T1D). The main outcome to be measured will be the percentage of time spent with a blood glucose less than 70mg/dl. This study is being...
Read More
